The S&P BSE Sensex surged 217 points to end at 25,736.
'The focus for value creation will be on all business segments.'
The Goa Children's Court had acquitted both last year.
Broader market outperformed with the S&P BSE Midcap index adding 0.7%, while S&P BSE Smallcap index gained 0.6%.
The Serum Institute of India, Bharat Biotech and Pfizer have applied to the DCGI seeking emergency use authorisation for their COVID-19 vaccine candidates and are awaiting approval.
The Ranbaxy experience has made multinational corporations more cautious about Indian acquisitions in general
Six government employees, including two policemen, were on Wednesday dismissed from service for their alleged links with terrorists in Jammu and Kashmir, taking the total number of employees sacked in last nearly six months to 25, officials said.
A Russian court sentenced US basketball star Brittney Griner to nine years in prison on Thursday after finding her guilty of deliberately bringing cannabis-infused vape cartridges into Russia, a ruling that President Joe Biden called "unacceptable."
After Maggi, the sample of macroni pasta was taken from Mau and sent to National Food Analysis Laboratory.
In the advisory, Union Home Secretary Ajay Bhalla said States and Union Territories may consider imposing need based, local curbs and restrictions, to control the crowd during the festive season.
In March, he had said that China is responsible for the spread of the novel coronavirus and called the COVID-19 as the "Chinese Virus".
Researchers claim to have developed a new treatment for ovarian cancer that can increase the rate of tumour shrinkage and prolong the time until cancers recur.
The deadly virus, which has killed over 5,000 people globally, has spread to 46 of the 50 US states.
Cambridge, Massachusetts-based Moderna's announcement comes just a week after Pfizer and Biontech said their COVID-19 vaccine candidate was found to be more than 90 per cent effective in preventing COVID-19 in participants.
Terming the situation as scary, Nath also said there was a shortage of Remdesivir injections used in the treatment of coronavirus, and alleged that the key anti-viral drug and oxygen were available only on paper and not in reality.
In a tweet, Prime Minister Narendra Modi said India is deeply honoured to be a 'long-trusted' partner in meeting the healthcare needs of the global community and that supplies of the vaccines to several countries will commence on Wednesday, and more will follow in the days ahead.
Nestle was perceived as being feeble in its defence.
Inspections only in domestic authorities' presence, visiting US drug regulator told
Consultants are working with various teams on manufacturing, R&D, etc, to assess per-month productivity of each department.
A second wave of Covid driven by the Delta variant engulfed the country in May-June bringing the health system to its knees and leaving people gasping for help.
Fast Moving Consumer Goods major Nestle may face more action by the Uttar Pradesh Food Safety and Drug Administration, which is testing more batches of Maggi after ordering recall of a batch of about 2 lakh packs of the instant noodles due to higher than permitted levels of lead and a food additive.
CBD oil, found in marijuana, is gaining popularity for its pain-relieving properties. It's now legally available in India
Taking part in the first meeting of Foreign Ministers of the neighbouring countries on Afghanistan, Foreign Minister Wang Yi said China will provide Afghanistan with 200 million yuan ($31 million) worth of grains, winter supplies, vaccines and medicines as per its requirements, official media in Beijing reported.
'If a doctor is kind of trying to say that there's an urgency, relatives should definitely get a second opinion.'
GE Healthcare has already filed five global patents for its design.
The first 100 beneficiaries of such foreign vaccines shall be assessed for seven days for safety outcomes before it is rolled out for further immunisation programme within the country, the Union health ministry said.
Details on prices sought as 10 generic drugs become up to 83 times costlier in 6 months
Addressing a press briefing, health ministry Joint Secretary Lav Agarwal said currently there are no approved therapies for COVID-19 and there is not enough evidence to claim that plasma therapy can be used for treatment of the disease.
Earning woes drag markets lower; TCS, HUL lead fall.
Pfizer and BioNTech said they have concluded phase 3 study of their mRNA-based COVID-19 vaccine candidate BNT162b2, meeting all primary efficacy endpoints.
Giving details of coronavirus situation in the country, Bhushan said the previous highest surge has already been crossed and the trend is going upward and that is a cause for worry and that is something they continuously share with the states and UTs and try to help them tackle the pandemic in a more effective manner.
Investors will maintain a cautious stance.
With the threat of COVID-19 pandemic continuing to loom over the world, the Ministry of Ayush has come out with a comprehensive document putting forth the concept of 'holistic health'.
According to the revised 'Clinical Management Protocols for COVID-19', dexamethasone which is already used in treating lung infections besides in a wide range of conditions for its anti-inflammatory and immunosuppressant effects can be used as an alternative to methylprednisolone which already existed in the treatment guidelines.
The under-one-minute films are titled 'Menu Cards, Mom and Neighbours'.
The meetings were a sign of crisis management.
Gennova has also got permission for phase-2 and 3 clinical trials for its lyophilised mRNA vaccine for injection from the subject expert committee advising the Central Drugs Standards Control Organisation, reports Sohini Das.
The test used now, called PCR (or polymerace chain reaction), uses a nasal or throat swab sample and identifies the virus. These tests take at least five hours to give results. The rapid test, on the other hand, uses a blood sample and gives results based on detecting the presence of certain antibodies that react to the coronavirus protein.
TCS, Infosys and Wipro were down 0.4-2% each. Capital goods majors also ended lower with L&T and BHEL down 1.4-3.9% each.
© 2026 Rediff.com - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances